UA81405C2 - Substituted pyridinones as modulators of p38 map kinase - Google Patents
Substituted pyridinones as modulators of p38 map kinaseInfo
- Publication number
- UA81405C2 UA81405C2 UA20040806790A UA20040806790A UA81405C2 UA 81405 C2 UA81405 C2 UA 81405C2 UA 20040806790 A UA20040806790 A UA 20040806790A UA 20040806790 A UA20040806790 A UA 20040806790A UA 81405 C2 UA81405 C2 UA 81405C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- map kinase
- modulators
- substituted pyridinones
- disclosed
- Prior art date
Links
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title abstract 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title abstract 2
- 150000005299 pyridinones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed. EMBED ISISServer , (I)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35702902P | 2002-02-14 | 2002-02-14 | |
| PCT/US2003/004634 WO2003068230A1 (en) | 2002-02-14 | 2003-02-14 | Substituted pyridinones as modulators of p38 map kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA81405C2 true UA81405C2 (en) | 2008-01-10 |
Family
ID=35986275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20040806790A UA81405C2 (en) | 2002-02-14 | 2003-02-14 | Substituted pyridinones as modulators of p38 map kinase |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101531631B (en) |
| UA (1) | UA81405C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2846663A1 (en) | 2011-08-29 | 2013-03-07 | Ptc Therapeutics, Inc. | Antibacterial compounds and methods for use |
| MX2014002297A (en) | 2011-08-29 | 2014-07-22 | Ptc Therapeutics Inc | Antibacterial compounds and methods for use. |
-
2003
- 2003-02-14 CN CN2009101351080A patent/CN101531631B/en not_active Expired - Fee Related
- 2003-02-14 UA UA20040806790A patent/UA81405C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101531631A (en) | 2009-09-16 |
| CN101531631B (en) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
| TW200517109A (en) | Substituted pyridinones | |
| MXPA05010621A (en) | Substituted pyrimidinones. | |
| MXPA05009359A (en) | 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators. | |
| MXPA05012678A (en) | CRYSTALLINE FORM OF beta2. | |
| TW200615266A (en) | Organic compounds | |
| GB0112348D0 (en) | Compounds | |
| MXPA05006420A (en) | Pyrimidine derivates for the treatment of abnormal cell growth. | |
| MXPA04005209A (en) | ADENOSINE A ??2a? RECEPTOR ANTAGONISTS. | |
| EA200400466A1 (en) | DERIVATIVES OF PIPERAZINE WITH ANTAGONISTIC ACTIVITY TO CCR1 RECEPTOR | |
| MXPA06009475A (en) | Quinazoline derivatives and therapeutic use thereof. | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| MXPA05012247A (en) | New benzimidazole derivatives. | |
| CY1109366T1 (en) | Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One | |
| EP1725536B8 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| ATE457027T1 (en) | SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF OBESITY | |
| HRP20010969B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, | |
| MXPA05004273A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives. | |
| BR0318521A (en) | arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods | |
| MXPA04005151A (en) | Therapeutic compounds. | |
| UA81405C2 (en) | Substituted pyridinones as modulators of p38 map kinase | |
| MXPA04001201A (en) | Tetracyclic indole derivatives as 5-ht receptor ligands. | |
| SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| NO20053805L (en) | Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof |